Bioscience Reports · 2019 · 41 citations · 27 references
Life SciencesCell BiologyPathobiologyCell SignalingInflammationSignal TransductionEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionFibrosisGrowth Factor SignalingInterstitial Lung DiseaseEpithelial-mesenchymal Transition MarkersLung FibrosisMesenchymal TransitionPi3k InhibitorsPi3k SignalingPi3k-akt Signaling PathwayPulmonary Fibrosis Progression
Idiopathic pulmonary fibrosis (IPF) is a fatal and chronic disease with a high rate of infection and mortality; however, its etiology and pathogenesis remain unclear. Studies have revealed that epithelial-mesenchymal transition (EMT) is a crucial cellular event in IPF. Here, we identified that the pulmonary fibrosis inducer bleomycin simultaneously increased the expression of bFGF and TGF-β1 and inhibited epithelial-specific regulatory protein (ESRP1) expression in vivo and in vitro. In addition, in vitro experiments showed that bFGF and TGF-β1 down-regulated the expression of ESRP1 and that silencing ESRP1 promoted EMT in A549 cells. Notably, we determined that bFGF activates PI3K/Akt signaling, and treatment with the PI3K/Akt inhibitor LY294002 inhibited bleomycin-induced cell morphology changes and EMT. In addition, the effects of LY294002 on bleomycin-induced EMT were inhibited by ESRP1 silencing in A549 cells. Taken together, these findings suggest that bleomycin induced EMT through down-regulating ESRP1 by simultaneously increasing bFGF and TGF-β1 in pulmonary fibrosis. Additionally, our findings indicated that bFGF inhibits ESRP1 by activating PI3K/Akt signaling.
27
Ganesh Raghu, Bram Rochwerg, Yuan Zhang et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 1.9K citations
ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
Claude C. Warzecha, Trey K. Sato, Behnam Nabet et al. · Molecular Cell · 2009 · 595 citations · Full text
Biological Roles of Fibroblast Growth Factor-2
Andréas Bikfalvi · Endocrine Reviews · 1997 · 465 citations